Novara Mark David
SEC CIK 2000342 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TNDM | TANDEM DIABETES CARE INC | EVP, Chief COMMERCIAL Off | 48.2K | $12.4K | $4,356 | 26 | 2024-11-15 | 2026-05-15 |
Most active insiders at TNDM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Novara Mark David | EVP, Chief COMMERCIAL Off | — | $4,356 |
| 2 | Malagueira Joao Paulo Falcao | Dir | — | — |
| 3 | Cha Myoungil | Dir | — | — |
| 4 | Hansen Shannon Marie | EVP, CLO | — | — |
| 5 | Gasser Elizabeth Anne | EVP, Chief Strategy Off | — | — |
| 6 | McGroddy-Goetz Kathleen | Dir | — | — |
| 7 | Kyrillos Jean-Claude | EVP, COO | — | — |
| 8 | Vosseller Leigh | EVP, CFO | — | — |
| 9 | Sodhi Rajwant | Dir | — | — |
| 10 | Morrison Susan | EVP, Chief Admin. Off | — | — |
Transactions 26
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-05-19 16:02 | 2026-05-15 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | M - OptEx | $0.00 | +10.6K | 48.2K | +28% | $0 |
| DM | 2026-05-19 16:02 | 2026-05-15 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | F - Tax | $12.82 | -7,911 | 40.3K | -16% | -$101.4K |
| D | 2026-03-18 | 2026-03-16 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | M - OptEx | $0.00 | +7,414 | 43.4K | +21% | $0 |
| D | 2026-03-18 | 2026-03-16 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | F - Tax | $21.59 | -5,540 | 37.8K | -13% | -$119.6K |
| D | 2026-03-18 | 2026-03-17 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | S - Sale+OE | $23.05 | -187 | 37.7K | -0.5% | -$4,310 |
| 2026-03-09 | 2026-03-05 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | S - Sale | $22.81 | -2 | 36.0K | -0.0% | -$45.62 | |
| D | 2026-02-19 | 2026-02-17 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | M - OptEx | $0.00 | +77 | 36.0K | +0.2% | $0 |
| D | 2026-02-19 | 2026-02-17 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | F - Tax | $18.95 | -62 | 36.0K | -0.2% | -$1,175 |
| D | 2025-12-17 | 2025-12-15 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | M - OptEx | $0.00 | +7,415 | 39.8K | +23% | $0 |
| D | 2025-12-17 | 2025-12-15 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | F - Tax | $22.11 | -3,843 | 36.0K | -10% | -$85.0K |
| D | 2025-11-19 | 2025-11-17 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | F - Tax | $18.61 | -40 | 32.4K | -0.1% | -$744.40 |
| D | 2025-11-19 | 2025-11-17 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | M - OptEx | $0.00 | +76 | 32.4K | +0.2% | $0 |
| D | 2025-09-16 | 2025-09-15 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | F - Tax | $12.09 | -3,866 | 32.3K | -11% | -$46.7K |
| D | 2025-09-16 | 2025-09-15 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | M - OptEx | $0.00 | +7,415 | 36.2K | +26% | $0 |
| D | 2025-08-19 | 2025-08-15 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | M - OptEx | $0.00 | +76 | 28.8K | +0.3% | $0 |
| D | 2025-08-19 | 2025-08-15 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | F - Tax | $10.82 | -40 | 28.8K | -0.1% | -$432.80 |
| D | 2025-06-18 | 2025-06-16 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | M - OptEx | $0.00 | +7,414 | 32.6K | +29% | $0 |
| D | 2025-06-18 | 2025-06-16 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | F - Tax | $20.76 | -3,846 | 28.8K | -12% | -$79.8K |
| D | 2025-05-19 | 2025-05-15 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | M - OptEx | $0.00 | +304 | 25.3K | +1% | $0 |
| D | 2025-05-19 | 2025-05-15 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | F - Tax | $22.70 | -113 | 25.2K | -0.4% | -$2,565 |
| D | 2025-05-19 | 2025-05-15 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | A - Grant | $19.30 | +870 | 25.0K | +4% | +$16.8K |
| D | 2025-03-19 | 2025-03-17 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | M - OptEx | $0.00 | +7,415 | 26.9K | +38% | $0 |
| D | 2025-03-19 | 2025-03-17 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | F - Tax | $19.17 | -2,739 | 24.1K | -10% | -$52.5K |
| D | 2024-12-18 | 2024-12-16 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | M - OptEx | $0.00 | +29.7K | 30.2K | +5,575% | $0 |
| D | 2024-12-18 | 2024-12-16 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | F - Tax | $32.66 | -10.7K | 19.5K | -36% | -$350.5K |
| 2024-11-19 | 2024-11-15 | TNDM | TANDEM DIABETES CARE INC | Novara Mark David | EVP, Chief COMMERCIAL Off | P - Purchase | $23.24 | +532 | 532 | New | +$12.4K |
Purchase Sale Sale after option exercise All abbreviations